Alto Neuroscience ANRO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.29M+103% | $12M+11.1% | $10.53M-19.4% | $13.12M-0.5% | $9.97M+0.2% | ||
| $6.84M+20.0% | $5.06M-18.4% | $4.43M-24.0% | $5.56M+7.8% | $5.7M+28.6% | ||
| $27.14M+73.1% | $17.06M+0.3% | $14.95M-20.8% | $18.68M+1.9% | $15.68M+9.0% | ||
| $27.14M+73.1% | $17.06M+0.3% | $14.95M-20.8% | $18.68M+1.9% | $15.68M+9.0% | ||
| -$27.14M-73.1% | -$17.06M-0.3% | -$14.95M+20.8% | -$18.68M-1.9% | -$15.68M-9.0% | ||
| $545K-8.9% | $575K+72.7% | $650K+86.2% | $646K+86.2% | $598K+72.8% | ||
| $1.56M-14.6% | $1.56M-26.9% | $1.53M-38.7% | $1.68M-36.7% | $1.83M+17.3% | ||
| $901K+77.7% | $873K-51.4% | $770K-63.4% | $976K-57.8% | $507K-47.7% | ||
| $0+100% | $0— | $0— | $0— | -$681K— | ||
| -$26.24M-73.0% | -$16.18M-6.5% | -$14.18M+15.5% | -$17.71M-10.5% | -$15.17M-13.1% | ||
| -$0.80-42.9% | -$0.45+19.6% | -$0.52+16.1% | -$0.65-8.3% | -$0.56+26.3% | ||
| -$0.80-42.9% | -$0.45+19.6% | -$0.52+16.1% | -$0.65-8.3% | -$0.56+26.3% | ||
| 32.9M+21.6% | 28.9M+17.3% | 27.1M+0.5% | 27.1M+0.6% | 27M+53.7% | ||
| 32.9M+21.6% | 28.9M+17.3% | 27.1M+0.5% | 27.1M+0.6% | 27M+53.7% | ||
| $7K-94.8% | $9K— | -$12K— | $22K— | $134K— | ||
| -$26.25M-74.3% | -$16.17M-6.4% | -$14.2M+15.4% | -$17.69M-10.3% | -$15.05M-12.2% | ||
| -$27.14M-73.1% | -$17.06M-0.3% | -$14.95M+20.8% | -$18.68M-1.9% | -$15.68M-9.0% | ||
| -$26.95M-73.8% | -$16.9M-0.4% | -$14.75M+21.1% | -$18.58M-1.9% | -$15.51M-8.5% | ||
| -$26.95M-73.8% | -$16.9M-0.4% | -$14.75M+21.1% | -$18.58M-1.9% | -$15.51M-8.5% | ||
| -$27.14M-73.1% | -$17.06M-0.3% | -$14.95M+20.8% | -$18.68M-1.9% | -$15.68M-9.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Alto Neuroscience profitable?
- Alto Neuroscience is not currently profitable: it reported a net loss of $74.3M over the trailing twelve months.
- What is Alto Neuroscience's earnings per share?
- Alto Neuroscience's diluted EPS over the trailing twelve months is $-2.42.
- Where does Alto Neuroscience's income statement data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.